Uhm Lab

The AI‑Driven Molecular Biomedicine Laboratory (AIMBL) integrates artificial intelligence, physical modeling, and experimental biology to create new molecular tools for precision medicine. Our research focuses on designing proteins that control cellular processes, engineering advanced CRISPR and prime‑editing systems, and building scalable pipelines that connect computation with high‑throughput wet‑lab validation.

We believe that the future of biomedical discovery lies in closed‑loop design–build–test–learn cycles, where generative models propose molecular solutions, experiments interrogate their function at scale, and data feed back into improved algorithms. AIMBL aims to establish this paradigm as a routine engine for biological innovation.